Motoh Iwasa

4.6k total citations · 1 hit paper
119 papers, 3.0k citations indexed

About

Motoh Iwasa is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Motoh Iwasa has authored 119 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 54 papers in Hepatology and 20 papers in Molecular Biology. Recurrent topics in Motoh Iwasa's work include Liver Disease Diagnosis and Treatment (59 papers), Liver Disease and Transplantation (38 papers) and Nutrition and Health in Aging (12 papers). Motoh Iwasa is often cited by papers focused on Liver Disease Diagnosis and Treatment (59 papers), Liver Disease and Transplantation (38 papers) and Nutrition and Health in Aging (12 papers). Motoh Iwasa collaborates with scholars based in Japan, United States and Germany. Motoh Iwasa's co-authors include Yoshinao Kobayashi, Masahiko Kaito, Naoki Fujita, Yoshiyuki Takei, Yukihiko Adachi, Hideaki Tanaka, Ryosuke Sugimoto, Akiko Eguchi, Naohito Urawa and Shozo Watanabe and has published in prestigious journals such as PLoS ONE, Cancer and Diabetes.

In The Last Decade

Motoh Iwasa

118 papers receiving 2.9k citations

Hit Papers

Evidence-based clinical p... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
    2021 179 citations Motoh Iwasa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Motoh Iwasa Japan 30 1.5k 1.0k 675 436 392 119 3.0k
Naoki Fujita Japan 29 859 0.6× 659 0.6× 469 0.7× 258 0.6× 366 0.9× 166 2.7k
Masataka Seike Japan 23 1.5k 1.0× 788 0.8× 434 0.6× 515 1.2× 133 0.3× 54 2.4k
Elmar Aigner Austria 32 1.5k 1.0× 509 0.5× 496 0.7× 480 1.1× 1.3k 3.2× 126 3.8k
Nicola De Maria Italy 32 1.8k 1.2× 1.9k 1.8× 574 0.9× 143 0.3× 152 0.4× 102 3.2k
Julie R. Jonsson Australia 28 2.6k 1.7× 2.1k 2.0× 432 0.6× 218 0.5× 175 0.4× 54 3.9k
Yoshikazu Murawaki Japan 35 1.7k 1.1× 1.8k 1.8× 1.0k 1.5× 231 0.5× 97 0.2× 196 4.1k
L. W. Powell Australia 20 1.3k 0.9× 589 0.6× 316 0.5× 162 0.4× 386 1.0× 58 2.3k
Christian Datz Austria 43 3.1k 2.1× 2.0k 2.0× 877 1.3× 481 1.1× 1.4k 3.6× 176 6.3k
Hisashi Tsurumi Japan 37 592 0.4× 268 0.3× 1.1k 1.6× 343 0.8× 348 0.9× 201 3.7k
Hideto Kawaratani Japan 27 1.3k 0.9× 917 0.9× 756 1.1× 212 0.5× 62 0.2× 136 2.6k

Countries citing papers authored by Motoh Iwasa

Since Specialization
Citations

This map shows the geographic impact of Motoh Iwasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoh Iwasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoh Iwasa more than expected).

Fields of papers citing papers by Motoh Iwasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motoh Iwasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoh Iwasa. The network helps show where Motoh Iwasa may publish in the future.

Co-authorship network of co-authors of Motoh Iwasa

This figure shows the co-authorship network connecting the top 25 collaborators of Motoh Iwasa. A scholar is included among the top collaborators of Motoh Iwasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoh Iwasa. Motoh Iwasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iwasa, Motoh, Akiko Eguchi, Yasuyuki Tamai, et al.. (2022). Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease. Frontiers in Medicine. 9. 982128–982128. 3 indexed citations
3.
4.
Tamai, Yasuyuki, Zhen Chen, Yue Wu, et al.. (2021). Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver. Biomedicine & Pharmacotherapy. 135. 111181–111181. 17 indexed citations
5.
Tamai, Yasuyuki, Motoh Iwasa, Akiko Eguchi, et al.. (2020). Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. PLoS ONE. 15(8). e0237370–e0237370. 42 indexed citations
6.
Yamamoto, Norihiko, Akiko Eguchi, Yoshifumi Hirokawa, et al.. (2020). Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(2). 57–60. 6 indexed citations
7.
Ishihara, Mikiya, Yoshihiro Miyahara, Junko Nakamura, et al.. (2019). First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer. Case Reports in Oncology. 12(1). 147–156. 30 indexed citations
8.
Toda, Masaaki, Taro Yasuma, Rumi Mifuji‐Moroka, et al.. (2017). Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin. Atherosclerosis. 265. 215–224. 8 indexed citations
9.
Iwasa, Motoh, Ryosuke Sugimoto, Nagisa Hara, Rumi Mifuji‐Moroka, & Yoshiyuki Takei. (2016). <b>Hyponatremia Observed in Hepatic Cirrhosis is Associated with Renal Function, Use of Diuretics and Survival</b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 47(1). 21–24. 2 indexed citations
10.
Iwasa, Motoh, Kazuko Iwata, Nagisa Hara, et al.. (2013). Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis. Nutrition. 29(11-12). 1418–1421. 62 indexed citations
11.
Kato, Akinobu, Hiroto Tanaka, Takumi Kawaguchi, et al.. (2012). Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open‐label study. Hepatology Research. 43(5). 452–458. 42 indexed citations
12.
Iwasa, Motoh, Nagisa Hara, Kazuko Iwata, et al.. (2010). Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease. Hepatology Research. 40(12). 1188–1194. 21 indexed citations
13.
Iwasa, Motoh, Nagisa Hara, Hideaki Tanaka, et al.. (2009). Patients achieving clearance of HCV with interferon therapy recover from decreased retinol‐binding protein 4 levels. Journal of Viral Hepatitis. 16(10). 716–723. 9 indexed citations
14.
Kaito, Masahiko, Motoh Iwasa, Naoki Fujita, et al.. (2007). Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin. Journal of Gastroenterology and Hepatology. 22(11). 1894–1897. 54 indexed citations
15.
Yamamoto, Mika, Motoh Iwasa, Kazuko Iwata, et al.. (2006). Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 22(4). 498–503. 62 indexed citations
16.
Iwasa, Motoh, Mikio Zeniya, Teru Kumagi, et al.. (2005). Modified diagnostic criteria of drug-induced liver injury proposed by the international consensus meeting.. PubMed. 52(63). 869–74. 5 indexed citations
17.
Horiike, Shinichiro, Shosuke Kawanishi, Masahiko Kaito, et al.. (2005). Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C. Journal of Hepatology. 43(3). 403–410. 49 indexed citations
18.
Iwasa, Motoh, Kaname Matsumura, Mika Yamamoto, et al.. (2003). Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. European Journal of Gastroenterology & Hepatology. 15(7). 733–737. 21 indexed citations
19.
Nakagawa, Naoki, Jiro Ikoma, Tomoaki Ishihara, et al.. (1999). High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma. Cancer. 86(8). 1437–1440. 19 indexed citations
20.
Iwasa, Motoh, et al.. (1996). Clinical significance of the globus pallidus signal intensity ratio in patients with liver cirrhosis.. Kanzo. 37(11). 626–631. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoki Fujita Breakdown of academic impact, for papers by Masataka Seike Breakdown of academic impact, for papers by Elmar Aigner Breakdown of academic impact, for papers by Nicola De Maria Breakdown of academic impact, for papers by Julie R. Jonsson Breakdown of academic impact, for papers by Yoshikazu Murawaki Breakdown of academic impact, for papers by L. W. Powell Breakdown of academic impact, for papers by Christian Datz Breakdown of academic impact, for papers by Hisashi Tsurumi Breakdown of academic impact, for papers by Hideto Kawaratani
Rankless by CCL
2026